That’s according to results from a company-sponsored clinical trial (NCT06037590) comparing the pharmacological properties of Levodopa Cyclops against those of Inbrija, an approved inhaled powder formulation of levodopa developed by Acorda Therapeutics.
“This randomized cross-over trial of Levodopa Cyclops vs. Inbrija in 26 healthy volunteers has shown that Levodopa Cyclops is at least as good and safe as Inbrija, showing a quicker absorption of levodopa during the first minutes,” Teus van Laar, MD, PhD, a neurologist and member of PureIMS’ scientific advisory board, said in a company press release.
The investigative formulation also is reported to be easier and more convenient for patients to use.
Immediate-Release Versus Controlled-Released Carbidopa-Levodopa 
ARE YOU A NON TREMOR DOMINANT PD PATIENT WITH DYSKINESIA? IF SO, PLEASE HELP.
Doctors use levodopa responsiveness to diagnose, but a new report today says a specific gut bacteria prevents it from getting to the brain
Liquefy your L-dopa
